Veracyte expands into Brazil; Sequenom's revenue jumps 20%;

@FierceMedDev: Veracyte is advancing into Brazil with its thyroid cancer Dx through an interesting new partnership. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: Updated with statement from company: Intuitive gets out from under FDA warning letter. Report | Follow @VarunSaxena2

@EmilyWFierce: More bad news for Endo: Company posted net losses of $436.9M and a drop in pharma sales in Q1. FiercePharma story | Follow @EmilyWFierce

@MichaelGFierce: ICYMI from FierceDrugDelivery: Oramed's oral insulin PhIIa details show a compromised study, and shares continue to fall. Article | Follow @MichaelGFierce

> Veracyte ($VCYT) inked a deal to get its thyroid cancer diagnostic into Brazil. Story

> Cleveland's Arteriocyte secured the FDA's blessing to launch a U.S. trial of its Magellan Bio-Bandage. News

> Sequenom ($SQNM) boosted its quarterly revenue by 20% year-over-year, bringing in $46.3 million thanks to increasing demand for its prenatal tests. Results

Biotech News

@FierceBiotech: EuroBiotech: Britain fearful of Pfizer future, UCB on the hunt for antibody partners, Novartis snubs Transgene. Report | Follow @FierceBiotech

@JohnCFierce: Vintafolide is toast, fails PhIII. Release | Follow @JohnCFierce

@DamianFierce: $AGN says it's "golf-course deprived" but stays mum on rumored bouncey castle, ski ball machine and raw juice bar. More from the WSJ | Follow @DamianFierce

@EmilyMFierce: Looking to sales growth, Merck rolls out vaccine adherence plan. More from FierceVaccines | Follow @EmilyMFierce

> FDA rejects The Medicines Co.'s clot-buster, sending cangrelor back to the clinic. News

> Pfizer jumps on the microbiome bandwagon with expansive Second Genome deal. More

> AstraZeneca bars the door, but Pfizer presses on with $106B buyout bid. Report

> Ex-champ Vertex dumps hep C, but shares spike on positive CF results. Story

Pharma News

@FiercePharma: Top-read special report: The top 10 pharma companies by 2013 revenue. Feature | Follow @FiercePharma

@TracyStaton: ICYMI this week: Allergan to propose to Shire again, but does Irish beauty want to get engaged? Story | Follow @TracyStaton

@EricPFierce: Taro expanding a plant in Canada. Provincial government will kick in about $10M of the $247M investment. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Takeda wins $70M from Japan to bump up H5N1 vaccine production. FierceVaccines story | Follow @CarlyHFierce

> Pfizer's approach may turn hostile after AZ rejects second offer. Story

> Sun is closing Caraco plant in Detroit and whacking nearly 180 jobs. Article

> Reports: Bayer closing in on deal for Merck OTC unit with Reckitt out of the way. More